Avacen Medical is a health care startup founded in 2012 in the United States with the slogan "Pain Relief from the Palm of Your Hand." The company is dedicated to providing noninvasive drug-free alternatives for pain management, including relief for conditions such as arthritis and fibromyalgia. Their flagship product, AVACEN100, is an FDA-cleared Class II medical device that utilizes heat therapy and negative pressure to increase local circulation and provide widespread pain relief. Avacen recently received CE Mark approval to treat widespread pain associated with fibromyalgia in the European Union, expanding its market reach. The company has secured 4 U.S. patents and multiple international patents for its innovative AVACEN Treatment Method (ATM), which covers therapeutic uses related to circulatory, neurological, lymphatic, or endocrinal dysfunctions. Their last recorded investment was a $2.00M equity crowdfunding investment in December 2014. Avacen's FDA clearance encompasses indications for the temporary relief of minor muscle and joint pain, stiffness, arthritis-related joint pain, muscle spasms, strains, sprains, and increase of local circulation. With its unique and innovative approach to pain relief, backed by patents and regulatory clearances, Avacen Medical presents an attractive investment opportunity in the health care sector, with potential for further market expansion and product development.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Equity Crowdfunding | $2.00M | - | 30 Dec 2014 | |
Equity Crowdfunding | Unknown | - | 14 Sep 2012 |